STOCK TITAN

Illumina Inc Form 4 Filings

ILMN NASDAQ

Every Form 4 that Illumina Inc (ILMN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ILMN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ILMN filings page.

Rhea-AI Summary

Illumina, Inc. executive Patricia Leckman reported equity award activity. On February 12, 2026, she exercised 1,028 performance share units at an exercise price of $0, receiving the same number of Illumina common shares as a result of the company achieving at least 74% of specified performance criteria.

Following this conversion, her direct common stock holdings increased to 20,419 shares. On the same day, 424 shares of common stock were automatically disposed of at $114.44 per share to cover tax obligations tied to the award, leaving her with 19,995 shares owned directly after these transactions.

Rhea-AI Summary

Illumina’s VP and Chief Accounting Officer, Scott D. Ericksen, reported equity award activity involving performance-based shares. On 02/12/2026, 743 performance share units were exercised at an exercise price of $0, converting into 743 shares of Illumina common stock.

According to the footnote, these shares were awarded because the company achieved at least 74% of the applicable performance criteria under a March 1, 2023 performance share grant. On the same date, 306 common shares were disposed of at $114.44 per share in a tax-withholding transaction, leaving Ericksen with direct ownership of 13,923 Illumina common shares.

Rhea-AI Summary

Illumina director Scott Gottlieb reported an open-market purchase of company stock. On 02/09/2026, he bought 200 shares of Illumina common stock at a price of $117.81 per share. Following this transaction, he directly beneficially owned 12,723 shares of Illumina common stock.

Rhea-AI Summary

Illumina’s chief legal officer reported an insider sale of common stock. On December 12, 2025, the officer sold 323 Illumina shares at a price of $136.09 per share.

Following this transaction, the officer directly holds 17,887 shares of Illumina common stock.

Rhea-AI Summary

GRAIL, Inc. reported an insider transaction on a Form 4 involving a large sale of common stock. On 11/17/2025, a reporting person sold 1,000,000 shares of common stock, par value $0.001 per share, in an open-market transaction coded "S" at a price of $79.85 per share. After this sale, the reporting person beneficially owned 3,502,126 shares of GRAIL common stock in direct ownership form.

The remarks state that following this sale, the reporting person is no longer a 10% beneficial owner of GRAIL, and the filing is characterized as an exit filing by the reporting person. The form is filed for a single reporting person and indicates the transaction was not reported as part of a derivative security.

Rhea-AI Summary

Illumina (ILMN) reported an insider trade by its Chief Legal Officer. On 11/12/2025, the officer disposed of 323 shares of common stock at $122.79 per share. Following the transaction, the officer beneficially owned 18,210 shares, held directly.

Rhea-AI Summary

Illumina (ILMN) reported an insider transaction on a Form 4 by its Chief Legal Officer, Scott M. Davies. On 11/05/2025, a transaction in 398 shares of common stock was recorded at $122.44 per share under transaction code F. Following this activity, Davies directly owned 18,533 shares of Illumina common stock.

Rhea-AI Summary

Illumina, Inc. (ILMN) reported an insider transaction by its VP, Chief Accounting Officer.

On 11/05/2025, 206 shares of common stock were disposed of at $122.44 under transaction code F. After this transaction, the reporting person beneficially owns 13,486 shares, held directly.

Rhea-AI Summary

Illumina (ILMN) insider transaction: The company’s SVP, Chief People Officer reported a Form 4 transaction on 11/05/2025. The filing shows a Code F entry for Common Stock with 296 shares disposed at $122.44 per share. Following this transaction, the officer beneficially owns 19,391 shares, held directly.

Rhea-AI Summary

Illumina, Inc. (ILMN) insider transaction reported. An officer (Chief of Global Operations) filed a Form 4 for a transaction on 11/05/2025. The filing reports the disposition of 599 shares of common stock at $122.44 per share with transaction code F.

Following the reported transaction, the insider beneficially owned 22,476 shares, held directly. The filing was made by one reporting person.

Rhea-AI Summary

Illumina, Inc. (ILMN) filed a Form 4 reporting an insider transaction by SVP & Chief Technology Officer Steven Barnard. The filing lists a 11/05/2025 transaction in which 515 shares of common stock were disposed of, coded “F,” at a price of $122.44 per share. After this transaction, Barnard directly beneficially owned 33,031 shares.

Rhea-AI Summary

Illumina (ILMN) reported an insider purchase on Form 4. Director Scott Gottlieb bought 500 shares of common stock on 11/03/2025 at $122.13 per share, raising his direct holdings to 12,523 shares. The filing indicates it was submitted by an authorized signatory on 11/05/2025.

Rhea-AI Summary

Jacob Thaysen, who is listed as Chief Executive Officer and a Director of Illumina, Inc. (ILMN), reported a sale of company stock on 10/05/2025. The filing shows 1,301 shares were disposed of at a price of $101.02 per share. After the transaction the reporting person beneficially owned 82,089 shares, held in a direct ownership form. The Form 4 was signed on 10/07/2025.

Rhea-AI Summary

Scott B. Ullem, a director of Illumina, Inc. (ILMN), reported on Form 4 that on 09/30/2025 he acquired 252 shares of Illumina common stock issued in lieu of cash retainer fees at an implied price of $99.1666 per share. Following the transaction he beneficially owns 8,389 shares, held directly. The filing states Mr. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock, with share counts determined using the quarter’s volume-weighted average closing price. The form is signed on 10/02/2025.